Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-08-10
1994-02-15
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548503, A61K 3140, C07D20908
Patent
active
052867404
ABSTRACT:
The present invention concerns novel carbamoyl derivatives of formula I, set out herein, which antagonize the pharmacological actions of one or more of the arachidonic acid metabolites known as leukotrienes, making them useful whenever such antagonism is desired, such as in the treatment of those diseases in which leukotrienes are implicated, for example, in the treatment of allergic or inflammatory diseases, or of endotoxic or traumatic shock conditions. The invention also provides pharmaceutical compositions containing the novel derivatives for use in such treatments, methods for their use and processes and intermediates for the manufacture of the novel derivatives.
REFERENCES:
patent: 4918094 (1990-04-01), Bernstein et al.
Gassen, Karl-Rudolf et al., Chem. Ber., (1986), 119, 2233-2248.
Imperial Chemical Industries plc
Jackson Thomas E.
Lee Mary C.
McKane Joseph K.
LandOfFree
Carbamoyl derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carbamoyl derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbamoyl derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1207215